EP 4188600 A1 20230607 - DEVICE FOR SEPARATION AND/OR PRESERVATION OF A BIOFLUID AT A POINT-OF-CARE, KIT AND METHOD FOR IDENTIFYING A DISEASE
Title (en)
DEVICE FOR SEPARATION AND/OR PRESERVATION OF A BIOFLUID AT A POINT-OF-CARE, KIT AND METHOD FOR IDENTIFYING A DISEASE
Title (de)
VORRICHTUNG ZUR TRENNUNG UND/ODER KONSERVIERUNG EINER BIOFLÜSSIGKEIT AM VERSORGUNGSORT, KIT UND VERFAHREN ZUR IDENTIFIZIERUNG EINER KRANKHEIT
Title (fr)
DISPOSITIF DE SÉPARATION ET/OU DE CONSERVATION D'UN FLUIDE BIOLOGIQUE AU NIVEAU D'UN POINT DE SOINS, ENSEMBLE ET PROCÉDÉ D'IDENTIFICATION D'UNE MALADIE
Publication
Application
Priority
- EP 20188456 A 20200729
- EP 2021070215 W 20210720
Abstract (en)
[origin: WO2022023114A1] The present invention relates to a device (1) for separation and/or preservation of non-cellular components from a biofluid sample (2) at a point-of-care, wherein said device (1) comprises at least one separation member (50) configured to separate the non-cellular components from the sample (2) and to retain cellular components, at least one extraction member (60) configured to extract the non-cellular components from the separation member (50), at least one flow assay (70) configured to analyze the non-cellular components extracted by the extraction member (50), and a housing (10) in which the separation member (50), the extraction member (60) and the flow assay (70) are arranged, wherein the housing (10) is configured to be shifted from a first configuration (A) to a second configuration (B), wherein, in the first configuration (A), the separation member (50) and the extraction member (60) are fluidly coupled with each other so that the device (1) is configured for extracting the non-cellular components from the separation member (50) by the extraction member (60), and wherein, in the second configuration (B), the separation member (50) and the extraction member (60) are fluidly uncoupled from each other for preventing a preservative (4) added to the separation member (50) from reaching the extraction member (60) and/or the flow assay (70).
IPC 8 full level
CPC (source: EP US)
B01L 3/5023 (2013.01 - EP US); B01L 7/00 (2013.01 - EP); C12Q 1/701 (2013.01 - US); B01L 2200/025 (2013.01 - EP); B01L 2200/0631 (2013.01 - EP US); B01L 2200/0668 (2013.01 - EP); B01L 2200/10 (2013.01 - EP); B01L 2200/16 (2013.01 - US); B01L 2300/0636 (2013.01 - EP); B01L 2300/0681 (2013.01 - EP US); B01L 2300/069 (2013.01 - EP US); B01L 2300/0803 (2013.01 - EP); B01L 2300/0825 (2013.01 - US); B01L 2300/0832 (2013.01 - EP); B01L 2400/0406 (2013.01 - EP US); B01L 2400/0644 (2013.01 - EP); B01L 2400/065 (2013.01 - EP); C12Q 1/6844 (2013.01 - US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2022023114 A1 20220203; EP 4188600 A1 20230607; EP 4188600 B1 20240605; US 2023243003 A1 20230803
DOCDB simple family (application)
EP 2021070215 W 20210720; EP 21746476 A 20210720; US 202118007206 A 20210720